Remote Jobs at Definium Therapeutics
Find your next remote opportunity · 11 Open Positions
Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine.
We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives.
From day one, we have been powered by a radical idea: treatments for anxiety and depression should bring real relief.
Together we’re moving psychiatry forward— beyond better, into a boundless future.
Definium Therapeutics trades on the NASDAQ under the symbol DFTX.
Regional Director – Site Engagement, Access
Regional Director leading field teams that prepare treatment sites and improve reimbursement access. Supporting Definium Therapeutics’ psychedelic and psychiatric therapy launches.
Senior Clinical Trial Manager
Senior Clinical Trial Manager overseeing clinical trials, CROs, vendors, and regulatory-quality delivery. Advancing psychedelic and psychiatric therapeutics at Definium Therapeutics.
Manager, Data & Analytics
Manager leading commercial analytics for Definium Therapeutics, a biopharmaceutical company developing psychedelic-based psychiatric treatments. Building scalable insights, reporting, and data solutions for commercial leadership.
Director, Pharmaceutical Development – Drug Product Manufacturing
Pharmaceutical development director leading outsourced drug product manufacturing, validation, packaging, and CDMO governance. Advancing psychedelic therapeutics for psychiatric and neurological disorders at Definium Therapeutics.
Director, Patient Services – Patient Strategy
Patient Services strategy director leading DT120 launch at Definium Therapeutics, a clinical biopharmaceutical company developing psychedelic-based psychiatric treatments. Designing compliant patient journeys, REMS support, workflows, and commercial readiness.
Director, Patient Services – Site of Care Strategy
Patient Services leader driving site-of-care strategy for Definium Therapeutics’ DT120 launch. Developing REMS, treatment-center readiness, workflows, and compliant patient-support operations.
Senior Director, Commercial Finance
Senior Director leading commercial finance for Definium Therapeutics, a late-stage psychiatric biopharmaceutical company. Driving forecasts, launch readiness, resource allocation, and performance management.
Associate Director, Regulatory Affairs – Advertising and Promotion
Associate Director guiding FDA advertising and promotion compliance for Definium Therapeutics, a biopharmaceutical company developing psychedelic treatments. Leading promotional review, FDA interactions, submissions, and MLR strategy.
Director, Product Communications
Director of Product Communications at Definium Therapeutics leading strategic communication for late-stage pipeline. Overseeing external and internal narratives, preparing for potential product launches.
Senior Director, Marketing
Senior Director, Marketing responsible for launching DT120 at Definium Therapeutics. Leading strategic marketing plans while collaborating with regulatory, medical, and sales teams to achieve corporate goals.
Vice President, Sales – Neuroscience
Vice President of Sales leading the sales team for Definium Therapeutics' commercial launch of DT120. Building and scaling a high-performing sales organization in the neuroscience area.
No more jobs available.